Initiative Overview: On World No Tobacco Day, Cipla Health Limited conducted multi‑city on‑ground screening and awareness campaigns in Mumbai, Bangalore and Chennai, aiming at early detection of tobacco‑related health risks and facilitating sustained quitting.
Partnerships: Mumbai camp partnered with the Indian Medical Association; Bangalore activation was in collaboration with Krishnadevaraya College of Dental Science & Hospital at Krantivira Sangolli Rayanna Bengaluru Railway Station; Chennai effort teamed with Saveetha Dental College for a week‑long outreach (May 25‑31 2026).
Target Audience & Scale: Mumbai camps (June 3 & 5 2026) focused on BMC workers, expecting ~100 participants on June 5 and a similar number on other dates. Bangalore outreach targeted high‑footfall commuters and station staff. Chennai activities engaged identified tobacco users through education, counseling and product sampling. Overall, the program reached more than 1,500 individuals across the three cities.
Screening Services: Camps offered oral cancer examinations and lung health assessments, providing early diagnostics and referrals for further care where needed.
Leadership Commentary: Mr. Shivam Puri, MD & CEO of Cipla Health Ltd., highlighted the growing intent to quit tobacco in India and the need to move beyond intent to sustained support, emphasizing Nicotex’s role in the cessation journey. Dr. Usha Chennuru, Medical Advisor, stressed that early‑stage tobacco‑related conditions often lack symptoms, making regular screening crucial for prompting quit attempts.
Product & Digital Support: The initiative showcased Cipla Health’s nicotine‑replacement therapy brand Nicotex and introduced Nicotex Begin, a first‑of‑its‑kind smoking‑cessation mobile app that combines NRT with behavioural support, claimed to increase quit success odds by up to five times. The Breathefree platform was also highlighted for lung health diagnostics and continued care.
Company Background: Cipla Health Limited, incorporated in 2015 as the fast‑moving wellness goods (FMWG) arm of Cipla, now manages a portfolio of 20 brands across categories such as Pain Care (Omnigel), Smoking Cessation (Nicotex), Oral Rehydration (Prolyte), Medicated Ointments (Cipladine), Cough & Cold (Cofsils, Naselin), Multi‑Vitamins (Maxirich), Weight Gain (Endura Mass), and Personal Care (Rivela Dermascience, Cetafresh, Tugain Essentials, Astaberry).
